INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • Observe the viability of your cells with the field-upgradeable cellular imaging option for the SpectraMax i3/i3x Multi-mode Detection Platform.

  • See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.

  • Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.

  • Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  • As a dedicated center of excellence in this product family, we offer a high degree of versatility and tailored solutions to meet the specific needs of each client.